financetom
Business
financetom
/
Business
/
Sable Offshore Launches $250 Million Private Placement of Shares; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sable Offshore Launches $250 Million Private Placement of Shares; Shares Rise
Nov 10, 2025 7:19 AM

09:54 AM EST, 11/10/2025 (MT Newswires) -- Sable Offshore ( SOC ) said Monday it has signed subscription agreements to issue nearly 45.5 million shares in a private placement at $5.50 per share, for expected gross proceeds of about $250 million.

The private placement is expected to close on Wednesday, the company said, adding proceeds will be used for general corporate purposes.

The offering will satisfy the common equity contribution condition of a recently disclosed senior secured term loan amendment, Sable said.

Sable shares were up 24% in early trading.

Price: 6.61, Change: +1.28, Percent Change: +24.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Dalata Hotel Group plc
Form 8.3 - Dalata Hotel Group plc
Sep 16, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed,...
Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditions
Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditions
Sep 16, 2025
COPENHAGEN, Sept 16 (Reuters) - Novo Nordisk plans to examine in clinical trials whether its future weight-loss drugs can treat a wide range of health conditions linked to obesity, as it has already begun doing with its blockbuster drug Wegovy. The Danish drugmaker aims to build evidence across both severe and more common obesity-related conditions that affect patients' daily lives,...
Market Chatter: Novo Nordisk to Seek FDA Approval for Higher Dose Wegovy
Market Chatter: Novo Nordisk to Seek FDA Approval for Higher Dose Wegovy
Sep 16, 2025
07:53 AM EDT, 09/16/2025 (MT Newswires) -- Novo Nordisk ( NVO ) intends to file a request with the US Food and Drug Administration for approval of a higher dose version of its weigh-loss drug Wegovy, Bloomberg reported Tuesday. Chief Scientific Officer Martin Holst Lange said that at a higher dose Wegovy is just as effective as Eli Lilly's (LLY)...
Carlyle, Nomura to Sell Stakes in Orion Breweries
Carlyle, Nomura to Sell Stakes in Orion Breweries
Sep 16, 2025
07:48 AM EDT, 09/16/2025 (MT Newswires) -- Carlyle Group ( CG ) and Nomura (NMR) are selling a part of their holdings in Japanese brewer Orion Breweries' upcoming initial public offering, a regulatory filing by Orion Breweries showed Tuesday. Carlyle Group ( CG ) will sell about 13.5 million shares, while Nomura is looking to offload approximately 14 million shares,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved